BEGIN:VCALENDAR
VERSION:2.0
PRODID:www.dresden-science-calendar.de
METHOD:PUBLISH
CALSCALE:GREGORIAN
X-MICROSOFT-CALSCALE:GREGORIAN
X-WR-TIMEZONE:Europe/Berlin
BEGIN:VTIMEZONE
TZID:Europe/Berlin
X-LIC-LOCATION:Europe/Berlin
BEGIN:DAYLIGHT
TZNAME:CEST
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
DTSTART:19810329T030000
RRULE:FREQ=YEARLY;INTERVAL=1;BYMONTH=3;BYDAY=-1SU
END:DAYLIGHT
BEGIN:STANDARD
TZNAME:CET
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
DTSTART:19961027T030000
RRULE:FREQ=YEARLY;INTERVAL=1;BYMONTH=10;BYDAY=-1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
UID:DSC-21344
DTSTART;TZID=Europe/Berlin:20241018T110000
SEQUENCE:1729229941
TRANSP:OPAQUE
DTEND;TZID=Europe/Berlin:20241018T120000
URL:https://www.dresden-science-calendar.de/calendar/de/detail/21344
LOCATION:MPI-CBG\, Pfotenhauerstraße 10801307 Dresden
SUMMARY:Pedrero: Keap1 deletion rescues cell death associated with Gpx4 los
 s in hepatocytes during acute liver injury
CLASS:PUBLIC
DESCRIPTION:Speaker: Leticia Colyn Pedrero\nInstitute of Speaker: Departmen
 t of Internal Medicine III\, University Hospital RWTH Aachen\, Germany\nTo
 pics:\n\n Location:\n  Name: MPI-CBG (MPI-CBG: Galleria)\n  Street: Pfoten
 hauerstraße 108\n  City: 01307 Dresden\n  Phone: +49 351 210-0\n  Fax: +4
 9 351 210-2000\nDescription: Acute liver failure (ALF) is a life-threateni
 ng condition with limited treatment options beyond liver transplantation i
 n non-acetaminophen cases. The extensive loss of liver function results fr
 om severe hepatocyte death\, where elevated reactive oxygen species (ROS) 
 play a significant role. Nuclear factor erythroid-2 like 2 (Nrf2) is cruci
 al in ROS defense by regulating genes such as glutathione peroxidase 4 (GP
 X4)\, which prevents lipid peroxidation (LPO). GPX4 is involved in several
  regulated cell processes\, including apoptosis and ferroptosis. GPX4 expr
 ession was measured in liver samples from healthy individuals\, ALF\, and 
 acute-on-chronic liver failure (ACLF) patients. To investigate GPX4's role
 \, mice with hepatocyte-specific deletion of Gpx4 (Gpx4&amp\;#916\;hepa) a
 nd both Gpx4 and the Nrf2 repressor\, Keap1\, (Gpx4&amp\;#916\;hepaKeap1&a
 mp\;#916\;hepa) were generated. ALF was induced in mice using a carbon tet
 rachloride (CCl4) and a bile duct ligation (BDL) cholestasis model\, each 
 lasting 48 hours. ALF patients exhibited reduced GPX4 levels compared to h
 ealthy individuals and ACLF patients\, consistent with observations in CCl
 4-treated wild- type mice. ALF-induced Gpx4&amp\;#916\;hepa mice exhibited
  increased hepatocyte death and liver dysfunction upon CCl4 treatment\, wi
 th increased apoptosis despite no changes in LPO markers. Activation of Nr
 f2 in Gpx4&amp\;#916\;hepaKeap1&amp\;#916\;hepamice reversed CCl4-induced 
 damage\, reducing necrosis and apoptosis markers while inducing anti-apopt
 otic BCL2. Our results demonstrate that Gpx4 plays a critical role in ALF 
 as its absence leads to hepatocyte apoptosis. Activating Keap1-dependent p
 athways targeting antioxidant defense system and upregulating BCL2 provide
 s substantial protection against ALF in mice lacking Gpx4 in hepatocytes. 
 Our findings suggest that the Keap1-Nrf2 axis is a promising therapeutic t
 arget in ALF.
DTSTAMP:20260730T102655Z
CREATED:20241010T054117Z
LAST-MODIFIED:20241018T053901Z
END:VEVENT
END:VCALENDAR